MarketCap
Facebook
X
TelegramGeschäftsbericht 2023
hinzugefügt 08.03.2024
Land |
 Vereinigte Staaten |
IPO-Jahr |
2006 |
Branche |
Arzneimittelhersteller |
Börse |
NYSESPB |
Anteile |
51.2 M |
Marktkapitalisierung |
$ 632 M |
EBITDA (LTM) |
$ -238 M |
P/E (LTM) |
-1.65 |
P/S (LTM) |
0.55 |
EPS (LTM) |
-7.51 |
Andere Aktien der Branche "Arzneimittelhersteller"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
 |
Alimera Sciences
ALIM
|
- | - | $ 142 M | Nasdaq Global Market | USA |
 |
Aerie Pharmaceuticals
AERI
|
- | - | $ 754 M | Nasdaq Global Market,SPB | USA |
 |
Canopy Growth Corporation
CGC
|
$ 1.19 | 4.39 % | $ 128 M | Nasdaq Global Select Market |  Canada |
 |
AcelRx Pharmaceuticals
ACRX
|
- | 7.5 % | $ 6.35 M | Nasdaq Global Market | USA |
 |
Adamis Pharmaceuticals Corporation
ADMP
|
- | 0.86 % | $ 117 M | Nasdaq Capital Market | USA |
 |
Cronos Group
CRON
|
$ 2.68 | 1.71 % | $ 1.4 B | Nasdaq Global Market | Canada |
 |
Catalent
CTLT
|
- | - | $ 11.5 B | NYSE,SPB | USA |
 |
Agile Therapeutics
AGRX
|
- | 10.11 % | $ 58.2 M | Nasdaq Capital Market | USA |
 |
Eagle Pharmaceuticals
EGRX
|
- | -39.89 % | $ 27.7 M | Nasdaq Global Market,SPB | USA |
 |
Endo International plc
ENDP
|
- | - | $ 28.9 M | Nasdaq Global Select Market,SPB |  Irlanda |
 |
Evoke Pharma
EVOK
|
- | - | $ 36.6 M | Nasdaq Capital Market | USA |
 |
Aurora Cannabis
ACB
|
$ 4.31 | 2.15 % | $ 86.3 M | NYSE | Canada |
 |
DURECT Corporation
DRRX
|
- | - | $ 50.1 M | Nasdaq Capital Market | USA |
 |
Calliditas Therapeutics AB (publ)
CALT
|
- | -0.1 % | $ 2.03 B | Nasdaq Global Select Market |  Schweden |
 |
HEXO Corp.
HEXO
|
- | 2.45 % | $ 38.1 M | NYSE | Canada |
 |
Jupiter Wellness
JUPW
|
- | - | $ 33.6 M | Nasdaq Global Select Market | USA |
 |
Athenex
ATNX
|
- | -23.39 % | $ 1.76 M | Nasdaq Global Select Market | USA |
 |
Avadel Pharmaceuticals plc
AVDL
|
$ 21.51 | -0.21 % | $ 2.05 B | Nasdaq Global Select Market |  France |
 |
Evolus
EOLS
|
$ 6.74 | 1.35 % | $ 418 M | Nasdaq Global Market | USA |
 |
Harrow Health
HROW
|
$ 48.75 | -0.51 % | $ 1.59 B | Nasdaq Global Market | USA |
 |
China Pharma Holdings
CPHI
|
$ 1.2 | -0.83 % | $ 21 M | NYSE American |  China |
 |
Neoleukin Therapeutics
NLTX
|
- | - | $ 193 M | Nasdaq Global Select Market | Canada |
 |
Organogenesis Holdings
ORGO
|
$ 4.85 | -6.31 % | $ 639 M | Nasdaq Capital Market | USA |
 |
OrganiGram Holdings
OGI
|
$ 1.74 | 3.27 % | $ 402 M | Nasdaq Global Select Market | Canada |
 |
Pacira BioSciences
PCRX
|
$ 24.76 | -4.33 % | $ 1.15 B | Nasdaq Global Select Market,SPB | USA |
 |
Bausch Health Companies
BHC
|
$ 6.97 | 0.36 % | $ 2.54 B | NYSE | Canada |
 |
Lannett Company
LCI
|
- | 1.15 % | $ 7.11 M | NYSE | USA |
 |
Cumberland Pharmaceuticals
CPIX
|
$ 3.91 | -1.76 % | $ 55 M | Nasdaq Global Select Market | USA |
 |
Sundial Growers
SNDL
|
$ 1.72 | 3.8 % | $ 3.37 M | Nasdaq Global Select Market | Canada |
 |
Sonoma Pharmaceuticals
SNOA
|
$ 3.57 | -1.88 % | $ 4.43 M | Nasdaq Capital Market | USA |
 |
Radius Health
RDUS
|
- | - | $ 1.42 B | Nasdaq Global Market | USA |
 |
Rockwell Medical
RMTI
|
$ 0.87 | 4.38 % | $ 20.3 M | Nasdaq Global Market | USA |
 |
PetIQ
PETQ
|
- | 1.64 % | $ 400 M | Nasdaq Global Select Market,SPB | USA |
 |
Perrigo Company plc
PRGO
|
$ 13.84 | -0.54 % | $ 1.9 B | NYSE | USA |
 |
Veru
VERU
|
$ 2.21 | 3.27 % | $ 298 M | Nasdaq Capital Market | USA |
 |
ProPhase Labs
PRPH
|
$ 0.44 | -1.5 % | $ 6.97 M | Nasdaq Capital Market | USA |
 |
Recro Pharma
REPH
|
- | -4.76 % | $ 65.3 M | Nasdaq Global Select Market | USA |
 |
cbdMD
YCBD
|
$ 1.17 | -13.33 % | $ 5.05 M | NYSE American | USA |
 |
Relmada Therapeutics
RLMD
|
$ 4.51 | -6.63 % | $ 136 M | Nasdaq Global Select Market,SPB | USA |
 |
OptiNose
OPTN
|
- | - | $ 1.08 B | Nasdaq Global Select Market | USA |
 |
Assertio Holdings
ASRT
|
$ 9.43 | 3.92 % | $ 670 M | Nasdaq Capital Market | USA |
 |
PLx Pharma
PLXP
|
- | -27.8 % | $ 2.56 M | Nasdaq Capital Market | USA |
 |
Solid Biosciences
SLDB
|
$ 5.45 | -3.37 % | $ 222 M | Nasdaq Global Select Market,SPB | USA |
 |
SCYNEXIS
SCYX
|
$ 0.63 | -0.98 % | $ 30.1 M | Nasdaq Global Select Market | USA |
 |
Tricida
TCDA
|
- | - | $ 3.25 M | Nasdaq Global Select Market,SPB | USA |
 |
Tilray
TLRY
|
$ 9.56 | 5.88 % | $ 5.91 B | Nasdaq Global Select Market | Canada |
 |
TherapeuticsMD
TXMD
|
$ 1.6 | -1.84 % | $ 16.7 M | Nasdaq Global Select Market | USA |
 |
Viatris
VTRS
|
$ 12.38 | -0.6 % | $ 15 B | Nasdaq Global Select Market,SPB | USA |
 |
Zynerba Pharmaceuticals
ZYNE
|
- | - | $ 55.5 M | Nasdaq Global Market,SPB | USA |